A variety of specialized materials are being used in today’s medtech environment. Many of these materials are only made suitable for the intended finished use by applying a customized surface treatment. These treatments can result in reduced friction, improvement of haptic properties, the introduction of chemical functionalities, and improved medium resistance of the materials. To meet this growing demand, Freudenberg Medical uses traditional coating methods at all of their global facilities. These include such methods as wet chemicals and state-of-the-art plasma treatments in order to alter the surface properties of medical components.
Freudenberg Medical is the leading provider of surface coating technologies for medical devices. We develop and manufacture innovative drug device combination products like drug eluting stents and drug-coated balloon catheters. As an organization, we hold over 100 technology patents in surface modification and drug delivery technologies. Our services include customized design and process development, prototyping, scalable contract manufacturing, regulatory support, and flexible individualized business models.
Freudenberg Medical addresses the growing market of devices for natural orifice surgery (NOS) and other minimal invasive procedures, e.g. stent-grafts and other covered scaffolds. Meshed structures with complex geometries can do multiple tasks: restore anatomical structures, assist compartmentalization, prevent in-growth of tissue, correct organ dysfunction, and even systemic disorders.
Based on a decade´s expertise in thin-walled elastomeric coatings on meshed structures of variable 3D complexity, we are offering custom design and manufacturing of devices covered with highly elastic, robust liners of biocompatible elastomers such as PU and silicone rubber.
The elastomeric surface can be further enhanced with special functionalities such as wet and dry lubricity or controlled release of active substances.
Lubricous coatings on medical devices reduce the adverse effects of dynamic and static friction. The performance, accuracy and durability of products is increased.
In clinical practice and scientific studies, our drug coatings have been proven to improve the functionality and safety of implants. We have extensive experience in adapting our patented coating platforms, with a range of drugs, to various implant designs for the following applications:
We have achieved pioneering work when it comes to drug coatings for balloon catheters by advancing the technology of “drug-coated balloons” (DCB). Many DCB concepts developed in collaboration with prestigious customers have now been granted regulatory approval. The “drug-coated balloon" is gaining ever increasing importance on the market and is opening up new options for vascular interventions. We are currently showcasing a new generation of balloon coatings that have been tailored to the specific characteristics of the drug Paclitaxel.